Vertex Is Trying To Replace Its Biggest Drug — Does It Stand A Chance?
Investor's Business DailyVertex could bolster its cystic fibrosis franchise with a next-generation drug, analysts said Tuesday. But VRTX stock dipped.
The post Vertex Is Trying To Replace Its Biggest Drug — Does It Stand A Chance? appeared first on Investor's Business Dai…